Effect of in vivo treatment with L-asparaginase on the in vitro uptake and phosphorylation of some antileukemic agents.
D000818:Animals; D000963:Antimetabolites / Q000378:metabolism*; D001215:Asparaginase / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D003561:Cytarabine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005472:Fluorouracil / Q000378:metabolism; D007930:Leucine / Q000031:analogs & derivatives / Q000378:metabolism; D007942:Leukemia, Experimental / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D015122:Mercaptopurine / Q000378:metabolism; D008727:Methotrexate / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D010085:Oxidative Phosphorylation / Q000187:drug effects; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013997:Time Factors
D000963:Antimetabolites; D003561:Cytarabine; D015122:Mercaptopurine; D013762:Tetrahydrofolate Dehydrogenase; D001215:Asparaginase; D007930:Leucine; D005472:Fluorouracil; D008727:Methotrexate